<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: S12 Nonclinical Biodistribution Considerations for Gene Therapy Products; International Council for Harmonisation; Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: S12 Nonclinical Biodistribution Considerations for Gene Therapy Products; International Council for Harmonisation; Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2023-05-01 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "S12 Nonclinical Biodistribution Considerations for Gene Therapy Products." The guidance was prepared under the auspices of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The final guidance provides harmonized recommendations for the conduct and overall design of nonclinical biodistribution (BD) studies for gene ...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2023-09179</p>
    <p><strong>Publication Date:</strong> 2023-05-01</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2023/05/01/2023-09179/s12-nonclinical-biodistribution-considerations-for-gene-therapy-products-international-council-for">https://www.federalregister.gov/documents/2023/05/01/2023-09179/s12-nonclinical-biodistribution-considerations-for-gene-therapy-products-international-council-for</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2023-09179</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
